1 / 8

Daily Equity Reports 18 Feb 2019

Capitalstars, financial research private limited is a SEBI Registered, provide Stock Tips,Share Market Tips , commodity &amp; currency tips.<br>http://www.capitalstars.com/tracksheet-stock-tips/<br>

PeehuSharma
Download Presentation

Daily Equity Reports 18 Feb 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 18 THFEBRUARY 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  2. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report INDIANFACE INDIAN MARKET CLOSE PREVIOUS ! INDIAN registered strong recovery from the day's low point with Niftyabletocloseabove10,700level.TheSensexwasdown EQUITY BENCHMARK -Benchmark indices NIFTY 67.27pointsat35808.95,whileNiftywasdown21.60points at10724.40.About911shareshaveadvanced,1581shares declined,and136sharesareunchanged. GLOBALFACE CLOSE PREVIOUS NIKKEI 2196.09 2225.85 ! AsianMarket- Asianmarketsfinishedsharplylowertoday withsharesinHongKongleadingtheregion.TheHangSeng isdown1.87%whileChina'sShanghaiCompositeisoff1.37% CLOSE CHANGE (%) CNX 100 andJapan'sNikkei225islowerby1.13%. S&P CNX 500 8827.05 ! U.S.Market– NorthandSouthAmericanmarketsfinished mixedas ofthemostrecentclosingprices.TheBovespa 4445.25 gained2.27%andtheIPCrose1.04%.TheS&P500lost 0.27%. CNX 200 5571.10 BANK NIFTY TOP GAINERS ! CLOSE CHANGE (%) Europeanmarkets- Europeanmarketsaremixedtoday.The CAC40isup0.74%whiletheFTSE100gains0.23%.TheDAX isoff0.04%. 3.83 3.05 GAIL 2.94 2.77 TOP LOSERS CLOSE CHANGE (%) -4.99 2,555.95 -4.17 SUNPHARMA -4.06 2,687.00 -3.21 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  3. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NIFTYSPOT MARKET MOVERS UPSIDE TREND BEARISH STRATEGY SCRIPT CLOSE (%) 3.83 BPCL 327.5 PIVOT POINTS 2.44 S3 10379 S2 10544 R1 10799 R2 10875 R3 11040 INFRATEL 10634 10710 2.23 ONGC S1-10629 S2-10554 R1-10812 R2-10901 1.95 MARKET MOVERS DOWNSIDE CLOSE (%) -4.99 JSWSTEEL -3.17 TATASTEEL IBULHSGFN -3.11 -2.89 NET BUY (CR.) NET SELL (CR) STRATEGY SELL ON RISE BEARISH 5405.02 PIVOT POINTS P 26883 S1 26677 R1 27046 R2 R3 27621 DII 3416.14 26146 26514 27252 RESISTANCE NSE TOTALS ADVANCE BANK NIFTY S NIFTY BANK NIFTY Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  4. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report MARKET TALKS ! Oral! LupinlaunchesClobazam Suspension,2.5mg/ml JetAirwaysgains4%asboardapproves debtresolutionplan Shares of Jet Airways gained 4% in intraday trade on Fridayafteritsboardapprovedadebtresolutionplan. ThesharesjumpedtoahighofRs242.85,ajumpofRs17 from its previous close of Rs225.80 on the BSE. The airlinecompanyisallsettoreceiveanemergencyloanof ~Rs600cr($85mn)totideoveracashcrunch,amedia reportsaid.Asperthereport,theairlinecompanymay get the loan from banks led by State Bank of India against the shares pledged by Founder and Chairman Naresh Goyal and partner Etihad Airways PJSC and backedbytheirguarantees. LupininitsfilingtotheexchangesonFridayinformedthat the company has launched Clobazam Oral Suspension 2.5mg/mLafterhavingreceivedapprovalfromtheUnited States Food and Drug Administration (USFDA) earlier. "Lupin's Clobazam Oral Suspension, 2.5mg/mL is the generic version ofLundbeck Pharmaceuticals LLC's Onfi OralSuspension,2.5mg/ml,"thecompanysaidinapress notetotheexchangesonFriday. ! AlembicPharmagetsUSFDAapprovalfor Moxifloxacin Ophthalmic AlembicPharmaceuticalshasreceivedapprovalfromthe USFDA for its ANDA Moxifloxacin Ophthalmic Solution USP, 0.5%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Vigamox Ophthalmic Solution USP, 0.5%, of Novartis Pharmaceuticals Corporation, the company said in a regulatory filing. Moxifloxacin Ophthalmic Solution USP, 0.5%hasanestimatedmarketsizeof$68mnfortwelve months ending December 2018, according to IQVIA. Alembichasacumulativetotalof86ANDAapprovals(73 finalapprovalsand13tentativeapprovals)fromUSFDA, thefilingadded. ! ZeeEntertainmentintalkswithComcastand Sonytosellstake:Mediareports PromotersofZeeEntertainmentandEsselGroupareintalks withUSmediagiantComcastandJapanesemultinational conglomerateSonyCorporationtosell~50%oftheirholdingsin thefirmasapartoftheirassetmonetizationtorepaydebt, CNBC-TV18reported.Asperthereport,bidsbyboththe companiesareintherangeofRs540-560/shareandthe promotersofthecompanymayinkanexclusivebinding agreementthisweek.AsonDecember31,2018,promotersheld 41.62%stake,thereportadded. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  5. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NAME OF THE STOCK : COALINDIA DATE : 18/02/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENTADVICE: CALLCS CALL:- BUY COALINDIA IN CASH NR CMP 219-220 TGT 224 SL 215 RATIONALEFORARRIVINGINVESTMENTADVICE: TECHNICALVIEW: THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF TREND REVERSAL IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  6. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

  7. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  8. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

More Related